🇺🇸 FDA
Patent

US 7470776

Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

granted A61KA61K38/08A61K38/14

Quick answer

US patent 7470776 (Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof) held by The Board of Regents of the University of Oklahoma expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/08, A61K38/14